454
Participants
Start Date
September 7, 2023
Primary Completion Date
September 30, 2026
Study Completion Date
September 30, 2029
IMRT and concurrent cisplatin
Patients receive concurrent cisplatin 100mg/m2 every 21days for three cycles during Intensity modulated radiotherapy (IMRT)
gemcitabine and cisplatin (Induction chemotherapy)
Patients receive gemcitabine (1000 mg/m² d1,8) and cisplatin (80mg/m² d1) every 3 weeks for 3 cycles before radiotherapy
NOT_YET_RECRUITING
Zhongshan City People's Hospital, Zhongshan
NOT_YET_RECRUITING
The First Affiliated Hospital of Guangxi Medical University, Nanning
NOT_YET_RECRUITING
Guangzhou Panyu Central Hospital, Guangzhou
RECRUITING
Sun Yat-sen University Cancer Center, Guangzhou
NOT_YET_RECRUITING
Cancer Hospital of Guizhou Province, Guiyang
NOT_YET_RECRUITING
Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology, Wuhan
NOT_YET_RECRUITING
Union Hospital, Tongji Medical College,Huazhong University of Science and Technology;, Wuhan
NOT_YET_RECRUITING
Hunan Cancer Hospital, Changsha
First Affiliated Hospital of Guangxi Medical University
OTHER
Zhongshan People's Hospital, Guangdong, China
OTHER
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
OTHER
Tongji Hospital
OTHER
Guangzhou Panyu Central Hospital
OTHER
Hunan Cancer Hospital
OTHER
Cancer Hospital of Guizhou Province
OTHER
Sun Yat-sen University
OTHER